Research and development through cross-functional collaboration between the business and research divisions
First written in FY2016. 11 of 23 entries say "Restated". Latest entry: FY2026.
11 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「To strengthen its research and development infrastructure, the company newly established three research institutes: the Marine Water Technology Research Institute, the Regenerative Medicine Research Institute, and the Gas Technology Research Institute.」
The cross-functional R&D structure has been given concrete form through the establishment of 3 research institutes specializing in seawater, regenerative medicine and core gas technologies. In addition, the Healthcare Development Center and the Agriculture & Food Development Center have been integrated to establish the Wellness Development Center. - 2026-05-22ReframedChanges in Officers
「We will establish a Technology Headquarters as an integrated organization bringing together the planning and oversight of technology strategy, promotion of research and development, development and innovation for creating new businesses, and oversight and control functions for quality, safety and the environment, which had previously been dispersed among business divisions and functions.」
The dispersed R&D and technology functions were reorganized into a Technology Headquarters integrating strategy, research, development and innovation, and quality, safety and environmental oversight and control. - FY2025ReframedAnnual report
「The company abolished the Group Technology Center and established the Technology Strategy Department, Intellectual Property Strategy Department and Gas Technology Development Center directly under the President as technology strategy functions, in order to accelerate technology and product development that contributes to the creation of new businesses across the Group.」
The Company is reorganizing its structure from cross-functional management by the Group Technology Center to a new business and product development structure comprising the Technology Strategy Department, Intellectual Property Strategy Department, and Gas Technology Development Center directly under the president. - FY2025-H1RestatedAnnual report
「Research and development expenses for the interim consolidated accounting period totaled ¥2,306 million.」
The Company continued its research and development activities and disclosed R&D expenses of ¥2,306 million for the interim consolidated accounting period. No changes to the existing cross-functional R&D structure were disclosed. - FY2024-Q3AdvancedAnnual report
「Air Water Performance Chemical Co., Ltd. Shonan Plant (Hiratsuka, Kanagawa) Digital & Industry New Research Building 3,000 February 2025」
A new plan has been finalized to construct a research building at the Shonan Plant, with a planned investment of ¥3 billion and completion scheduled for February 2025, to strengthen the R&D platform. - FY2024-Q1AdvancedAnnual report
「To realize new businesses through innovation at an early stage, the company established a Gas Technology Development Center dedicated to developing new applications for gas and set up development centers for each business area. It actively pursued the creation of new business models that contribute to solving social issues, including electronic and functional materials, decarbonization solutions, pulp regeneration therapy and land-based aquaculture.」
The company has given concrete form to a cross-functional R&D structure by establishing a Gas Technology Development Center and development centers for individual business areas, and is promoting the commercialization of initiatives addressing multiple social issues. - FY2023AdvancedAnnual report
「During the consolidated fiscal year, the company established a Group Technology Center to manage on a cross-functional basis the broad range of technologies dispersed across the Group and worked to create new value through coordination and integration.」
Cross-functional collaboration in research and development was advanced toward the centralised management and integration of technologies by the Group Technology Center. R&D expenses were ¥5,451 million. - FY2023-Q2RestatedAnnual report
「Research and development expenses for the cumulative second quarter of the current consolidated fiscal year totaled ¥2.806 billion.」
The company continues its research and development activities and reported R&D expenses of ¥2,806 million for the cumulative second-quarter consolidated period. - FY2023-Q1AdvancedAnnual report
「As part of its efforts to build business models related to resource circulation and new energy, the company developed a small-scale CO2 capture unit, ReCO2STATION, and began initiatives aimed at commercializing CO2 capture and utilization.」
CO2 capture and utilisation technology advanced from the research and development stage to the launch of initiatives aimed at developing and commercialising the small-scale capture unit "ReCO2STATION." - FY2022-Q2RestatedAnnual report
「Research and development expenses for the cumulative second quarter of the current consolidated fiscal year totaled ¥2,451 million.」
The Company continued its research and development activities and disclosed R&D expenses of ¥2,451 million for the cumulative second quarter of the consolidated fiscal year. No changes to the existing cross-functional collaboration structure or new technology milestones were disclosed. - FY2021AdvancedAnnual report
「The company developed the next-generation VHR hydrogen gas generator, which produces hydrogen gas from city gas with world-leading efficiency, and has commenced operation of 4 units to date. It will continue to expand sales to meet robust hydrogen demand in fields such as steel and semiconductors, while contributing to the environment through energy conservation.」
VHR has progressed from the development stage to the stage of commencing operation of 4 units, and aims to expand sales in response to hydrogen demand. The disclosure also addresses industry-government-academia collaboration aimed at implementing CO2 capture and utilisation technologies in society. - FY2021-Q3RestatedAnnual report
「Total research and development expenses for the cumulative third quarter of the current consolidated fiscal year were ¥2,518 million.」
The company continues its research and development activities and disclosed R&D expenses of ¥2,518 million for the nine-month period. No new changes were reported in the cross-functional R&D framework. - FY2021-Q2RestatedAnnual report
「Research and development expenses for the cumulative second quarter of the current consolidated fiscal year totaled ¥1.672 billion.」
R&D activities continued, and R&D expenses of ¥1,672 million for the cumulative second quarter were disclosed. - FY2020AdvancedAnnual report
「We established the Technology Strategy Center as the core organization of the group's technology platform. By centrally managing the group's technology resources across organizational boundaries and supporting research and development in each business area, the center will seek to create higher-value-added products and services than ever before.」
Cross-functional collaboration between the former business and research divisions is being developed into integrated management of the Group's technology resources by the Technology Strategy Center. R&D is also progressing on practical-use-oriented themes such as VHR, CO2 capture and utilization, and GaN substrates. - FY2020-Q3RestatedAnnual report
「Total research and development expenses for the first 3 quarters of the current consolidated cumulative period were ¥2,436 million.」
Research and development activities continued, with research and development expenses of ¥2,436 million disclosed for the cumulative third quarter period. No changes to the existing cross-functional collaboration policy or new R&D milestones were described. - FY2020-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second-quarter period were ¥1,426 million.」
R&D activities continued, and R&D expenses of ¥1,426 million for the cumulative second quarter were disclosed. No changes to the cross-functional collaboration policy or new R&D milestones were stated. - FY2020-Q1RestatedAnnual report
「Total research and development expenses for the cumulative first quarter period were ¥683 million.」
The company continued its research and development activities and disclosed research and development expenses of ¥683 million for the cumulative first quarter. - FY2019-Q3RestatedAnnual report
「Total R&D expenses for the 3rd quarter of the current consolidated cumulative period were ¥2.137 billion.」
Research and development activities continued, and research and development expenses of ¥2,137 million for the cumulative third quarter were disclosed. No changes to the existing cross-functional collaboration policy or new research and development milestones were reported. - FY2019-Q2RestatedAnnual report
「Total research and development expenses during the cumulative second-quarter consolidated period were ¥1,389 million.」
The company continues its R&D activities and disclosed R&D expenses of ¥1,389 million for the cumulative second-quarter period. No changes to the existing cross-functional collaboration policy or new R&D milestones were disclosed. - FY2018AdvancedAnnual report
「In application equipment, the dry-ice cleaning system using carbon dioxide was fully launched on the market. In application development, the new carburising gas, which reacts rapidly with metal surfaces, has been shown to be effective in customers' mass-production furnaces, and negotiations toward adoption are under way. In addition, the company completed development of a room-based shower and bathing system that reduces the burden of transferring persons requiring nursing care, with a grant from the Japan Agency for Medical Research and Development, and plans to launch it on the market shortly.」
The company reported progress toward commercializing R&D成果, including the full-scale market launch of a dry ice cleaning system, verification of the effects of a new carburizing gas in a mass-production furnace, and completion of development of a shower bathing system for residential rooms. R&D expenses were ¥2,775 million. - FY2018-Q3RestatedAnnual report
「Total research and development expenses for the cumulative third quarter of the consolidated fiscal year under review were ¥2,061 million.」
The company disclosed the continuation of R&D activities and R&D expenses of ¥2,061 million for the first 3 quarters. There has been no new change to the existing policy of cross-functional collaboration itself. - FY2017AdvancedAnnual report
「In its research and development activities for the fiscal year, the Company continued to seek to maximize the efficiency of research and development investment. The business divisions, operating companies, and research divisions engaged in extensive cross-functional discussions and initiatives, formulated research and development strategies aligned with business strategies, and promoted these activities to contribute to the rapid creation and development of businesses while optimizing management resources. In addition, SiC-on-Si substrates incorporating these technologies, as well as GaN-on-SiC-on-Si substrates, have been manufactured at the plant, samples have been supplied to customers and evaluation is progressing, and efforts are being made toward adoption.」
While continuing its cross-functional R&D policy, the company has progressed to plant manufacturing of SiC on Si substrates and GaN on SiC on Si substrates, as well as the supply and evaluation of customer samples. R&D expenses were ¥2,832 million. - FY2016First statedAnnual report
「With the aim of maximizing the efficiency of R&D investment, the research division holds extensive discussions with each business division and operating company, formulates R&D strategies aligned with their business strategies, and advances R&D activities based on a common understanding.」
To maximise the efficiency of R&D investment, the Company has institutionalised coordination among its business divisions, operating companies and research divisions. R&D expenses are ¥2.9 billion.